New York 10 Hour Physician Package (includes DEA MATE Act)
Included Courses
Courses included in this package. Click on a course to learn more.
- Infection Control in Healthcare Settings 2Course release date: 1/1/2020
Target Audience:
This course is designed for all physicians and other health care providers licensed in the state of New York.
About the Course:
The purpose of this course is to provide physicians with an up-to-date training covering all topic areas related to infection control and prevention that are mandated by the New York State Department of Health. The course focuses on pathogen transmission pathways in healthcare settings, strategies for preventing or limiting direct and indirect transmission, and the range of work practice controls used to prevent transmission, contain or remove potentially infectious spills, and to disinfect/sterilize medical devices and instruments.
Maintenance of Certification (MOC) information can be viewed here: MOC Recognition Page - Substance Use Disorders: A DEA Requirement 8
Course release date: 5/30/2023
About the Course
Physicians and Physician Assistants (PAs), care for patients with disorders in many healthcare settings. Individuals may seek care for an acute illness or worsening of a chronic condition. Often, pain is the leading reason for seeking medical care. Appropriate prescribing practices are critical for all medications, but controlled substances require special attention. The Drug Enforcement Agency (DEA), the Food and Drug Administration (FDA), and the U.S. Department of Health and Human Services (HHS) all have a role in controlled medication schedules. Prescribers must understand federal and state requirements for all controlled substances. This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances. Additionally, substance use disorders are complex phenomena affecting many lives. This course also reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
“This course will fulfill the DEA-mandated 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for DEA licensees renewing on or after June 27, 2023.”